Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, MC 0657, La Jolla, California, 92093-0657, USA.
Pharm Res. 2018 Feb 6;35(3):45. doi: 10.1007/s11095-017-2287-z.
One impediment to breastfeeding is the lack of information on the use of many drugs during lactation, especially newer ones. The principles of drug passage into breastmilk are well established, but have often not been optimally applied prospectively. Commonly used preclinical rodent models for determining drug excretion into milk are very unreliable because of marked differences in milk composition and transporters compared to those of humans. Measurement of drug concentrations in humans remains the gold standard, but computer modeling is promising. New FDA labeling requirements present an opportunity to apply modeling to preclinical drug development in place of conventional animal testing for drug excretion into breastmilk, which should improve the use of medications in nursing mothers.
母乳喂养的一个障碍是缺乏哺乳期使用许多药物(尤其是新型药物)的信息。药物进入母乳的原理已得到充分证实,但往往没有得到前瞻性的最佳应用。常用于确定药物排入乳汁的临床前啮齿动物模型由于与人类相比,乳汁成分和转运蛋白存在显著差异,因此非常不可靠。测量人体中的药物浓度仍然是金标准,但计算机建模很有前途。新的 FDA 标签要求为应用模型替代传统的动物试验来进行临床前药物开发提供了机会,以确定药物排入母乳中的情况,这有望改善哺乳期妇女对药物的使用。